Mycosis Fungoides Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
Conditions:   Adult T-Cell Lymphoma/Leukemia;   Sezary Syndrome;   Mycosis Fungoides Interventions:   Drug: rhIL-15;   Biological: Mogamulizumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials

Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
Conditions:   Adult T-Cell Lymphoma/Leukemia;   Sezary Syndrome;   Mycosis Fungoides Interventions:   Drug: rhIL-15;   Biological: Mogamulizumab Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials